Old Web
English
Sign In
Acemap
>
authorDetail
>
Anne M. Noonan
Anne M. Noonan
The Ohio State University Wexner Medical Center
Durvalumab
Lung cancer
Adverse effect
Systemic inflammatory response syndrome
Rash
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
2021
Journal of Clinical Oncology
Karyn A. Goodman
Fang Shu Ou
Nathan Hall
Tanios Bekaii-Saab
Briant Fruth
Erin Twohy
Michael O. Meyers
Daniel J. Boffa
Kisha Mitchell
Wendy L. Frankel
Donna Niedzwiecki
Anne M. Noonan
Yelena Y. Janjigian
Paul J. Thurmes
Alan P. Venook
Jeffrey A. Meyerhardt
Eileen M. OReilly
David H. Ilson
Show All
Source
Cite
Save
Citations (2)
Safety and efficacy of the anti-CD73 monoclonal antibody (mAb) oleclumab ± durvalumab in patients (pts) with advanced colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), or EGFR-mutant non-small cell lung cancer (EGFRm NSCLC).
2021
Journal of Clinical Oncology
Johanna C. Bendell
Patricia LoRusso
Michael J. Overman
Anne M. Noonan
Dong-Wan Kim
John H. Strickler
Sang-We Kim
Stephen Clarke
Thomas J. George
Peter Grimison
Minal A. Barve
Manik Amin
Jayesh Desai
Trisha Wise-Draper
Zachary A. Cooper
Nairouz Elgeioushi
Nancy Mueller
Rakesh Kumar
Kevin Yufeng Wu
Sandip Pravin Patel
Show All
Source
Cite
Save
Citations (2)
1